T37.4X3 Poisoning by anthelminthics, assault

Name of the Condition

• Poisoning by anthelminthics, assault

Summary

This condition involves poisoning by anthelminthic medications resulting from assault, where exposure to these drugs is intentional and non-consensual. Anthelminthics are used to treat parasitic worm infections, and this code applies when the poisoning is a result of deliberate harm by another party. The condition may present with acute toxicity, requiring prompt medical evaluation and intervention.

Causes

Poisoning by anthelminthics in the context of assault occurs when an individual is intentionally exposed to these medications without consent. This may involve forced ingestion, injection, or other forms of administration with harmful intent. The focus is on the non-consensual nature of the exposure, distinguishing it from accidental or self-inflicted cases.

Risk Factors

• Proximity to individuals with access to anthelminthic medications.
• Situations involving conflict or violence.
• Lack of supervision or control over medication storage in vulnerable settings.
• History of interpersonal violence or abuse.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain, or diarrhea.
• Neurological: Dizziness, confusion, seizures, or altered mental status.
• Dermatological: Rash, itching, or hypersensitivity reactions.
• Systemic: Organ dysfunction (e.g., hepatic or renal) or metabolic disturbances.

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and confirmation of non-consensual exposure. Lab tests (e.g., drug levels, renal/hepatic function) and toxicology screening may be used to assess toxicity. Documentation of the assault context is critical for accurate coding and legal considerations.

Treatment Options

Treatment addresses acute toxicity and may include decontamination, supportive care (e.g., fluid resuscitation, antiemetics), and monitoring for organ dysfunction. Specific antidotes for anthelminthics are limited, so management is primarily symptomatic. Psychological support and safety planning are also important.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of exposure, and promptness of treatment. Early intervention improves outcomes, but severe toxicity can lead to long-term organ damage. Follow-up includes monitoring for delayed effects and addressing any underlying trauma or safety concerns.

Complications

• Severe organ dysfunction (e.g., hepatic or renal failure).
• Neurological sequelae (e.g., seizures, cognitive impairment).
• Psychological trauma related to the assault.
• Potential for legal or social consequences requiring additional support.

Lifestyle & Prevention

Prevention involves ensuring secure storage of medications, especially in environments where assault risk is present. Education on recognizing and reporting non-consensual exposure is key. Support systems for at-risk individuals may reduce vulnerability.

When to Seek Professional Help

Seek immediate medical attention if exposure to anthelminthics is suspected, particularly in the context of assault. Symptoms like severe gastrointestinal distress, neurological changes, or altered consciousness warrant urgent care. Legal and safety resources should also be engaged.

Tips for Medical Coders

Document the assault context clearly, including details of non-consensual exposure. Ensure the code T37.4X3 is used when poisoning by anthelminthics is directly linked to an assault. Differentiate from accidental or self-harm cases by verifying the intent and circumstances of exposure.